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osting by EAbstract Adenoid cystic carcinoma (ACC) of the salivary gland is characterized by a prolonged
but inevitably unfavorable clinical course. Recent studies have suggested that the transmembrane
tyrosine kinase receptor, c-kit proto-oncogene is involved in ACC pathogenesis. CD43 is a sialogly-
coprotein that is typically expressed by hematopoietic cells and their derivative neoplasms, although
positivity in epithelial tumors has only been recognized recently.
Objective: The aim of this study was to evaluate c-kit and CD43 immunoreactivity in ACCs and
to compare the extent of their expression in various histologically deﬁned subgroups of ACC, and
their probable involvement in ACC pathogenesis.
Study design: Formalin-ﬁxed parafﬁn-embedded sections from 35 ACCs were immunostained
for c-kit and CD43 using monoclonal antibodies.
Results: Cytoplasmic and membranous c-kit immunoreactivity was detected in 25/35 ACCs
(71.4%) with strong immunostaining observed in solid pattern of ACC. Cytoplasmic and membra-
nous CD43 immunoreactivity was detected in 18/35 (51.4%) of ACCs with strong immunostaining
seen in the cribriform pattern.
Conclusions: These results suggested that c-kit could be used as a prognostic marker for ACC
and speciﬁc c-kit tyrosine kinase inhibitors such as imatinib, might be used in future therapeutic
approaches against subgroups of ACC. CD43 appears to be preferentially expressed in salivary
gland ACCs. Its expression decreased with cellular dedifferentiation and there was an inverse rela-
tionship between immunoexpression of c-kit and CD43 among ACC of salivary gland.
ª 2009 King Saud University. All rights reserved.m (M.M. Ahmed).
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lsevier1. Introduction
Adenoid cystic carcinoma (ACC) is characterized by a slow,
but locally aggressive growth pattern along nerves and blood
vessels irreversibly destructing adjacent and surrounding tis-
sues of the head and neck region. Even though the 5-year over-
all survival is more than 70%, long-term outcome is much less
favorable declining to less than 10% after 20 years because of
28 M.M. Ahmed, E.A. Abo-Hagerlate local recurrences and distant metastases (Kokemueller
et al., 2004).
ACC shows three distinct histological differentiation types
with the cribriform subtype exhibiting islands of monomorphic
cells with punched-out spaces and the tubular subtype showing
narrow ductal structures within a ﬁbrous stroma. The latter is
supposed to have a better prognosis than the less differentiated
solid subtype, which is composed of basaloid tumor cells with
nuclear pleomorphism and high mitotic activity (Fordice et al.,
1999). Speciﬁc cytogenetic aberrations involved in initiation
and progression of these histologically deﬁned ACC subtypes
are infrequently found and only poorly described (Stallmach
et al., 2002).
The evolution of ACC is unpredictable in the individual
patient because of the lack of strong prognostic indicators.
Surgery and postoperative radiation remains the mainstay of
therapy. Although various chemotherapy regimens have been
tried, none has proved to be effective in the treatment of
ACC (Jeng et al., 2000).
The transmembrane tyrosine kinase receptor c-kit (CD117)
is a 145- to 165 Kd proto-oncogene that structurally belongs
to a family of receptors that include those for colony-stimu-
lating factor-1 (CSF-1) and platelet derived growth factor
(PDGF) (Vliagoftis et al., 1997; Jeng et al., 2000). After bind-
ing to the ligand (stem cell factor), dimerization, and phos-
phorylation, the receptor tyrosine kinase (c-kit) subsequently
activates a signaling cascade that regulates cell growth and
development of multiple hematopoietic cell lineages (Fletcher,
2004). In addition to hematopoiesis, c-kit has been shown to
play a role in normal migration and development of germ
cells and melanocytes (Funasaka et al., 1992; Jeng et al.,
2000).
The c-kit protein is required for normal hematopoiesis,
melanogenesis, and gametogenesis. Thus c-kit gene product
is expressed in several normal cell types including mast cells,
intestinal cells of Cajal, melanocytes, and epithelial cells of
breast (Edwards et al., 2003). Overexpression of the c-kit tyro-
sine kinase receptor occurs in a number of neoplasms, includ-
ing germ cell tumors (Izquierdo et al., 1995), gastrointestinal
stromal cell tumors (GISTs) (Sarlomo-Rikala et al., 1998),
malignant melanoma (Guerriere-Kovach et al., 2004), leuke-
mias, endometrial carcinomas, papillary and follicular thyroid
carcinomas, and ACC (Jeng et al., 2000; Edwards et al., 2003;
Chandan et al., 2004; Freier et al., 2005; Aslan et al., 2005;
Andreadis et al., 2006).
c-kit is a target of the tyrosine kinase inhibitor imatinib mes-
ylate (GleevecTM), which showed signiﬁcant treatment re-
sponse in patients with chronic myelogenous leukaemia
(CML) (O’Brien et al., 2003) and advanced c-kit-positive GIST
(Verweij et al., 2004).
CD43, also known as leukosialin, sialophorin, and gp115, is
a transmembrane sialoglycoprotein expressed on the cell sur-
face of most hematopoietically-derived cells, including T lym-
phocytes, granulocytes, monocytes, and platelets. Two
isoforms of CD43 exist that differ both in antigenicity and
molecular weight: the ﬁrst form possesses an afﬁnity for the
thymocyte/lymphocyte/monocyte cell lines (115-kDa form);
the second form favors the neutrophil/platelet cell lines
(135-kDaform) (Pimenidou et al., 2004). The molecular conﬁg-
uration of CD43 is similar to that of mucin, with multiple
sialylated O-glycan sites and a single N-linked glycan site
(Cruz-Muno˜z et al., 2003). Of note, the different isoforms ofCD43 appear to be determined by minor alterations in the gly-
cosylation pattern of this glycoprotein (Santana et al., 2000).
CD43 has been demonstrated to be a multifunctional pro-
tein with often paradoxical roles in a variety of cellular pro-
cesses. Its involvement in cellular adhesion events is directly
related to post-translational modiﬁcations of the extracellular
domain, such as high level of glycosylation and heavy sialyla-
tion; these modiﬁcations appear to facilitate cell–cell repulsion
or promote cell–cell adhesion, respectively (Cruz-Muno˜z et al.,
2003; Pimenidou et al., 2004). In addition, CD43 participates
in a complex signaling pathway that results in recruitment of
several signaling proteins, activation of protein kinase C
(PKC), AP-1, and NFjB, and direct induction of various
genes (Santana et al., 2000), ultimately culminating in activa-
tion of T lymphocytes and natural killer (NK) cells (Santana
et al., 2000; Cruz-Muno˜z et al., 2003).
CD43 expression can be seen on a number of neoplasms,
primarily of hematopoietic origin. Positive reactivity has been
demonstrated in a majority of T cells, mantle cell, small lym-
phocytic cells, and Burkitt’s lymphoma with less frequent
expression identiﬁed in nodal and extranodal marginal zone
lymphomas (Lai et al., 1999). Aberrant expression of CD43
has also been noted in plasmacytomas (Petruch et al., 1992;
Shin et al., 2001). Evidence also suggests a role for CD43 in
epithelial neoplasms. Study has demonstrated CD43 expres-
sion in the colon adenocarcinoma cell line COLO 205 (Bae-
ckstro¨m, 1997).
Seethala et al. (2004) documented aberrant expression of
CD43 in adenoid cystic carcinomas of salivary and mammary
glands origin. They reported preferential immunoreactivity of
CD43 in adenoid cystic carcinomas compared to non-adenoid
cystic carcinoma tumors included in their study.2. Materials and methods
A total of 35 adenoid cystic carcinomas of the salivary gland
were retrieved from the ﬁles of Department of Oral and Max-
illofacial Pathobiology, Graduate School of Medical Sciences,
Hiroshima University. Representative hematoxylin and eosin-
stained sections of all the tumors were reviewed to conﬁrm the
tumor type and to assign the differentiation grade (12 cribri-
form, 14 tubular and nine solid variants). Five fresh normal
salivary gland tissues serving as controls were collected from
sialadenectomy specimens and processed as usual for forma-
lin-embedded parafﬁn blocks for hematoxylin and eosin as
well as immunostaining.
For immunohistochemistry (IHC), Four micron serial sec-
tions were performed from each formalin ﬁxed parafﬁn-
embedded tissue blocks, mounted on charged slides and dried.
To enhance immunoreactivity, sections were subjected to
microwave heat treatment as follows: the slides were ﬁrst depa-
rafﬁnized, dehydrated in graded ethanol concentrations, and
incubated with 0.6% hydrogen peroxide in methanol for
10 min to block endogenous peroxidase activity. After rinsing
with water, the slides were placed in a glass dish ﬁlled with
10 mmol/L sodium citrate buffer, pH 6.0. Tissue sections were
boiled in a microwave oven twice for 5 min each to enhance
immunoreactivity. The slides were allowed to cool and rinsed
with phosphate-buffered saline (PBS), pH 7.2. The immuno-
histochemical staining was done according to the manufac-
turer’s instructions using. Anti c-kit (poly clonal, DAKO
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epitope retrieval on a NexES instrument (Ventana Medical
System, Tucson, AZ) and Anti CD-43 (clone L 60, Venta Med-
ical system, Inc, Tucson, AZ) at a 1:50 dilution . Detection was
carried out using DAKO universal kit (Glostrup, Denmark).
Slides were washed in PBS for 5 min and incubated with sec-
ondary antiserum that was biotinylated goat serum covalent
to rabbit and mouse serum for 30 min. Sections were then
washed for 5 min in PBS followed by development of anti-
gen–antibody visualization by diaminobenzidine [DAB in
PBS containing 40% hydrogen peroxide. Sections were washed
under running tap water for 10 min lightly, counter stained
with Mayer’s haematoxylin and mounted. Negative controls
were carried out on consecutive sections, using either an iso-
type antibody or omission of the primary anti-body resulting
in no detectable staining.3. Evaluation of immunostaining
Tumor cells with unequivocal staining of the cytoplasm or the
membrane were considered positive. Cases were divided into
three categories based on the percentage of positive cells and
intensity of c-kit and CD43 expression.
The immunostained sections were examined using light
microscope to assess the prevalence of positive cases and the
localization of immunostaining within the tissues. The image
analysis was performed using a computer system, Germany
(software Leica Qwin) consisting of color video camera, color
monitor, hard disc of hp personal computer connected to the
microscope, Oral Pathology Department, Faculty of Dental
Medicine for Girls, Al-Azhar University. Tumor cells with
unequivocal staining of the cytoplasm or the membrane were
considered positive for both c-kit and CD-43. The percentage
of positive cells was measured in the form of an area and area
percent inside a standard measuring frame of area
11434.9 lm2 per 10 ﬁelds using a magniﬁcation (40·) by light
microscopy then transferred to the monitor. These areas were
masked by a blue binary color using the software computer
system for measurement. Mean values were obtained for the
whole specimens.
The percentage of positive cells was scored as follows: 0 (0–
19%), 1 (20–39%), 2 (40–59%), and 3 (60–100%). The inten-
sity of expression was assessed according to the staining inten-
sity as grade 1 (mild), 2 (moderate), 3 (strong). The percentage
score and the intensity score were summed up to obtain the to-
tal score, which was graded as follows: mild for 1, moderate
for 2, and strong for 3, according to Lim et al. (2003).4. Statistical evaluation
Quantitative data of the image analyzer were ﬁrst summarized
and presented as means and standard deviation values. Analy-
sis of variance (ANOVA) was used to compare between means
of the three groups. Duncan’s post-hoc test was used to deter-
mine signiﬁcant differences between the means when ANOVA
test result was signiﬁcant. Qualitative data were presented as
frequencies and percentages. Chi-square (v2) test was used to
compare between the groups. The signiﬁcance level was set
at P 6 0.05. Statistical analysis was performed with SPSS15.0
(Statistical Package for social sciences) for Windows.5. Results
The ACC comprised of 35 cases, 13 men and 22 women with a
median age of 62 years (range: 50–81 years). The tumor sites
include 9 lesions from major salivary gland (2 parotid, 6 sub-
mandibular, 1 sublingual) and 26 lesions from minor salivary
gland (14 palate, 2 tongue, 1 lower lip, 8 ﬂoor of the mouth
(FOM), 1 retromolar), metastasis was reported in 6 cases,
(Table 1). All morphologic patterns classically described in
ACC, including cribriform, tubular, and solid, were presented.
Six cases showed metastasis, of which 4 cases were of solid pat-
tern and 2 cases were tubular.
The ﬁve normal salivary gland tissue specimens revealed
negative immunostaining for both c-kit and CD43. Consider-
ing c-kit, it was expressed by 25/35 cases of ACC (71.4%) with
cribriform pattern 7/12 (58.3%), tubular 10/14 (71.4%), solid
pattern 8/9 (88.8%) (Table 2), whereas, CD43 was expressed
by 18/35 cases (51.4%) exhibited a positive staining for
CD43 with cribriform pattern 10/12 (83.3%), tubular pattern
5/14 (27.7%), solid pattern 3/9 (33.3%), (Table 3).
Distribution of c-kit immunostaining was observed primar-
ily in the cytoplasm although when cytoplasmic staining was
strong, a membranous pattern of immunostaining was also ob-
served. The tubular and cribriform patterns showed c-kit
expression in the inner luminal cell layers of the tumor (Figs.
1A and 3A), whereas the solid pattern showed c-kit expression
in all neoplastic cells (Fig. 2A). For CD43, cytoplasmic and
membranous immunoreactivity was detected.
The immunostaining for c-kit varied in intensity from mild
to strong among different ACC subtypes. The solid pattern
showed strong immunopositivity (8/8), whereas tubular pat-
tern exhibited mild (1/10), moderate (8/10), strong (1/10)
immunopositivity. The cribriform patterns showed mild immu-
nopositivity (7/7). The four solid pattern that metastasized re-
vealed strong immunostaining, while the two tubular cases
showed negative staining.
Cytoplasmic CD43 immunostaining varied from mild to
strong among the ACC subgroups. Notably, there was a trend
towards more tumors without any immunostaining for CD43
in solid ACC than in cribriform/tubular ACC. Tumors exhib-
iting a strong immunostaining were only found in cribriform
and tubular compared to solid subtypes. The cribriform pat-
tern showed moderate immunostaining in (1/10 cases) and
strong immunostaining in (9/10 cases) (Fig. 1B), the tubular
pattern revealed moderate immunostaining in (4/5 cases) and
strong immunostaining in (1/5 cases) and mild immunostain-
ing (Fig. 3B), whereas, the solid variant showed mild immuno-
staining (2/3 cases) and moderate immunostaining (1/3 cases)
(Fig. 2B). Among the four solid pattern cases that metasta-
sized, 3 cases revealed negative immunostaining and one case
with mild immunostaining, while the two tubular pattern cases
revealed negative immunostaining.
For c-Kit, solid ACC showed statistically signiﬁcant highest
mean area percent. There was no statistically signiﬁcant differ-
ence between cribriform and tubular ACC which showed the
lowest mean value. There was no statistically signiﬁcant differ-
ence between mean optical densities of the three groups (Table
4) (Figs. 4 and 5).
For CD43, cribriform ACC showed the statistically signiﬁ-
cant highest mean area percent. This was followed by tubular
ACC. Solid ACC showed signiﬁcantly lowest mean. Cribri-
Table 2 Summary of IHC results of c-kit in ACC by histologic subtype.
IHC staining ACC subtype Number of cases Negative Mild Moderate Strong Total positive cells (%)
Cribriform 12 5 7 0 0 7 (58.3%)
Tubular 14 4 1 8 1 10 (71.4%)
Solid 9 1 0 0 8 8 (88.8%)
All subtypes 35 10 8 8 9 25 (71.4%)
Table 3 Summary of IHC results of CD43 in ACC by histologic subtype.
IHC staining ACC subtype Number of cases Negative Mild Moderate Strong Total positive cells (%)
Cribriform 12 2 0 1 9 10 (83.3%)
Tubular 14 9 0 4 1 5 (27.7%)
Solid 9 6 2 1 0 3 (33.3%)
All subtypes 35 17 2 6 10 18 (51.4%)
Table 1 Clinicopathological features and immunohistochemical results.
Case number Age Sex Location Pattern Metastasis C-kit CD43
1 40 M Palate Tubular  + 
2 76 M Lower lip Tubular  + 
3 55 F SM Cribriform  + +
4 78 F FOM Cribriform   +
5 65 F FOM Cribriform  + +
6 81 F FOM Cribriform   
7 77 F Tongue Tubular  + 
8 79 M Palate Tubular  + +
9 46 F FOM Cribriform   +
10 79 M Palate Solid  + 
11 40 M Palate Tubular   +
12 76 M Palate Cribriform  + +
13 84 F FOM Tubular  + 
14 74 F SM Cribriform  + 
15 65 M SM Solid  + +
16 79 F SM Tubular  + 
17 74 M SM Cribriform   +
18 37 F FOM Solid + + 
19 74 F Palate Solid + + 
20 48 F Retromolar Tubular +  
21 63 F FOM Tubular +  
22 45 F Palate Cribriform  + +
23 65 F Palate Tubular  + 
24 45 F Palate Cribriform   +
25 48 M Palate Solid  + 
26 64 F Palate Tubular  + +
27 58 M Parotid Tubular  + +
28 48 F Tongue Tubular   
29 48 F SLG Solid   
30 73 M Palate Solid  + +
31 30 F Palate Solid + + +
32 70 F SM Solid + + 
33 46 F FOM Cribriform  + +
34 65 M Parotid Tubular  + +
35 75 M Palate Cribriform  + +
F= female, M=male, SM= submandibular, SLG= sublingual gland, FOM= ﬂoor of mouth.
30 M.M. Ahmed, E.A. Abo-Hagerform ACC showed the statistically signiﬁcant highest mean
optical density. This was followed by tubular ACC. Solid
ACC showed the signiﬁcantly lowest mean (Table 4) (Figs. 4
and 5).6. Discussion
ACC is an extremely unpredictable tumor because of slow
growth, late metastases, and lack of strong prognostic mark-
Figure 1 Photomicrographs of (A). Cytoplasmic c-kit expression in cribriform pattern of ACC, predominantly in luminal cells (B).
Cytoplasmic and membranous CD43 expression in cribriform ACC (original magniﬁcation 200·).
Figure 3 Photomicrographs of (A). Cytoplasmic and membranous c-kit expression in tubular pattern of ACC, predominantly in luminal
cells (B). Cytoplasmic CD43 expression in tubular pattern of ACC (original magniﬁcation 200·).
Figure 2 Photomicrographs of (A). Cytoplasmic c-kit expression in solid form of ACC, predominantly in all neoplastic cells (B).
Cytoplasmic CD43 expression in solid form ACC, (original magniﬁcation 200·).
Differential expression of c-kit and CD43 in histological subtypes 31ers. In this study, there was an attempt to ﬁnd a correlation be-
tween c-kit and CD43 immunoexpression and tumor differen-
tiation of ACCs. As regard c-kit, a reverse relationship with
the degree of tumor differentiation was detected, while,CD43 showed a direct relationship as proved by highly signif-
icant statistical results.
The negative immunostaining of c-kit in normal salivary
gland tissues was in accordance with result of Chandan et al.
Table 4 Statistical results of mean Area percent and optical density for c-kit and CD43 among the ACC subgroup.
Cribriform Tubular Solid P-value
Mean SD Mean SD Mean SD
c-Kit Area percent 2.01b 0.9 3.31b 1.1 6.51a 1.4 0.027*
Optical density 68.6 5.9 72.6 8.3 74.1 9.1 0.164
CD43 Area percent 23.04a 1.2 9.68b 1.7 4.53c 1 <0.001*
Optical density 70.2a 8.4 62.1b 6.5 53.3c 4.3 <0.001*
* Signiﬁcant at P 6 0.05, means with different letters are statistically signiﬁcantly different according to Duncan’s test.
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Figure 5 Mean optical density of c-kit and CD43
immunoexpression.
32 M.M. Ahmed, E.A. Abo-Hager(2004). Which suggested that c-kit protooncogene may have no
role in salivary gland function rather initiation of salivary
gland tumors.
In this study, solid pattern of ACC showed the statistically
signiﬁcant highest mean area percent (P value = 0.027*) for c-
kit. There was no statistically signiﬁcant difference between
cribriform and tubular ACC which showed the statistically sig-
niﬁcant lowest means. There was no statistically signiﬁcant dif-
ference between mean optical densities of the three groups (P
value = 0.164).
The pattern of c-kit expression in ACC differed with the
histology subtype. Tubular and cribriform variants primarily
showed c-kit expression in the luminal cell layer. This sug-
gested that the myoepithelial cell did not express c-kit, as the
abluminal cells did not stain. This was in accordance with
study of Edwards et al. (2003) and Aslan et al. (2005). Para-
doxically solid variants showed expression in all cells most ofwhich are considered modiﬁed myoepithelial cells (Ellis and
Auclair, 1995). This difference in the pattern of c-kit expres-
sion in tubular and cribriform ACC, as compared with solid
variants of ACC, suggest a loss of cellular heterogeneity in so-
lid variants, with differentiation primarily along the line of the
luminal cell layer, and may correlate with the worse clinical
course of the solid variant of ACC seen in some studies
(Cruz-Muno˜z et al., 2003). These were in line with ﬁnding that
the strong immunopostivity detected in highly malignant solid
phenotype and mild immunopostivity detected in cribriform
pattern, which have clinical feature of moderate aggressive-
ness. These results were in accordance with study of Edwards
et al. (2003), Chandan et al. (2004) and Aslan et al. (2005).
Meanwhile, contradictory to these results Freier et al. (2005)
found that strong immunostaining of c-kit was only found in
cribriform and tubular but never in solid subtypes.
Previous studies reported that c-kit gene mutations or phos-
phorylation at the protein level was not detected in ACC, even
though the c-kit protein was over-expressed (Jeng et al., 2000;
Oliveira et al., 2003) in most tumors. These studies may sug-
gest that c-kit tyrosine kinase may not affect the natural his-
tory of ACC.
In this study, cribriform ACC showed the statistically sig-
niﬁcant highest mean area percentage for CD43 (P va-
lue =<0.001*). This was followed by tubular ACC. solid
ACC showed the statistically lowest mean. Cribriform ACC
showed the statistically signiﬁcantly highest mean optical den-
sity (P value =<0.001*). This was followed by tubular ACC.
Solid ACC showed the signiﬁcantly lowest mean. Both area
percentage and optical density goes in line with each other
for CD43 immunostaining.
According to present data, no expression of CD43 was ob-
served in nonneoplastic salivary gland tissue specimens.
Although weak focal staining ductal epithelial cells were ob-
served, this immunoreactivity was below the threshold for des-
ignation of positive staining in the current study. CD43
immunostaining is more frequently found in well-differentiated
tumors and might get lost during dedifferentiation of ACC,
indicating that different molecular pathways are involved in
the formation of histological ACC subtypes.
Both cribriform and tubular pattern showed strong to mod-
erate immunostaining for CD43, while, solid pattern revealed
mild to moderate CD43 immunostaining. This indicated that
CD43 is important in initiation of ACC rather than progres-
sion. These results were in accordance with results of Seethala
et al. (2008) as they found that the few high-grade, angioinva-
sive, ACC did not seem to express CD43. Contrary to these re-
sults, Woo et al. (2006) found that there were no difference in
immunostaining intensity observed when reactivity was as-
sessed according to ACC subtypes.
Differential expression of c-kit and CD43 in histological subtypes 33CD43 is a recognized receptor of intercellular adhesion
molecule-1 (ICAM-1, CD54), Rosenstein et al. (1991) a com-
plex, multifunctional molecule with major roles in trafﬁcking
of inﬂammatory cells and in antigen presentation to T lympho-
cytes ICAM-1 is widely expressed in cells of both hematopoi-
etic and non-hematopoietic origin, including epithelial,
endothelial, and ﬁbroblastic cells.
Previous study by Ziprin et al. (2003) reported that ICAM-1
expressed by mesothelial cells enhanced colorectal adenocarci-
noma cell attachment to the peritoneum. The same group later
demonstrated that cells expressing CD43, including three colo-
rectal adenocarcinoma cell lines, a pancreatic adenocarcinoma
cell line, and an ovarian carcinoma cell line, that had been previ-
ously incubated with anti-CD43 antibodies and anti-ICAM-1
antibodies, exhibited reduced adhesion to a mesothelial cell
monolayer Ziprin et al. (2004). These authors postulated that
the interaction between ICAM-1 and its ligand CD43 was likely
implicated in the development of peritoneal metastases of vari-
ous solid epithelial tumors Ziprin et al. (2004). Similarly, it is
possible that the CD43-ICAM-1 interaction participates in the
unique capacity of ACCs to undergo distant metastases, a char-
acteristic not shared by other salivary gland tumors.
In the current study, there was an inverse relationship be-
tween immunoexpression of c-kit and CD43 among ACC of
salivary gland. The uniform strong expression of c-kit seen
in this and previous studies of ACC suggested that c-kit may
be used as a prognostic marker in ACC. It also, suggested a
potential role for c-kit inhibitors such as imatinib mesylate
(GleevecTM), formerly STI-571, in the treatment of patients
with advanced ACC. CD43 appears to be preferentially ex-
pressed in salivary gland ACC, its expression decreases with
cellular dedifferentiation and there was an inverse relation be-
tween immunoexpression of c-kit and CD43 among ACC of
salivary gland.Acknowledgements
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